Absorption |
Blood-Brain Barrier | BBB+ | 0.9401 |
Human Intestinal Absorption | HIA+ | 0.9055 |
Caco-2 Permeability | Caco2+ | 0.6893 |
P-glycoprotein Substrate | Substrate | 0.9126 |
P-glycoprotein Inhibitor | Inhibitor | 0.5192 |
Non-inhibitor | 0.6992 |
Renal Organic Cation Transporter | Inhibitor | 0.5797 |
Distribution |
Subcellular localization | Mitochondria | 0.4709 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8366 |
CYP450 2D6 Substrate | Substrate | 0.8919 |
CYP450 3A4 Substrate | Substrate | 0.8142 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9153 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8692 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.6721 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7801 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8322 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9212 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8366 |
Non-inhibitor | 0.5860 |
AMES Toxicity | Non AMES toxic | 0.7448 |
Carcinogens | Non-carcinogens | 0.9391 |
Fish Toxicity | High FHMT | 0.8597 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9617 |
Honey Bee Toxicity | Low HBT | 0.5000 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.5506 |
Carcinogenicity (Three-class) | Non-required | 0.5940 |